Clinical Trial Update: Study of Qiliqiangxin Capsule to Treat Dilated Cardiomyopathy [Phase 4]

View source ↗

Summary

Phase 4 clinical trial of Qiliqiangxin Capsule assessing treatment of dilated cardiomyopathy and heart failure has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dilated Cardiomyopathy
• Heart Failure

Drugs mentioned

• Qiliqiangxin Capsule

Snippet

Sponsor: Huazhong University of Science and Technology | Conditions: Dilated Cardiomyopathy, Heart Failure | Phase 4 | Status: COMPLETED